Abciximab
At a glance
- Drug Originator Centocor
- Drug Licenced by Eli Lilly and Company
- Drug Class Antiplatelets; Fab fragments; Ischaemic heart disorder therapies; Monoclonal antibodies
- Mechanism of Action GPIIb-IIIa antagonists
- USA Patent Applicants CENTOCOR INC
- USA Patents 247
- BLAs 1
- International Patents 2,748
Disclaimer